# Autologous Bronchial Basal Cell Transplantation for Treatment of COPD

> **NCT03188627** · PHASE1,PHASE2 · COMPLETED · sponsor: **Regend Therapeutics** · enrollment: 24 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **BIOLOGICAL:** Bronchial basal cells

## Key facts

- **NCT ID:** NCT03188627
- **Lead sponsor:** Regend Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-12
- **Primary completion:** 2019-12-26
- **Final completion:** 2019-12-26
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03188627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03188627, "Autologous Bronchial Basal Cell Transplantation for Treatment of COPD". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT03188627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*